Presentation on Predicting and Protecting Against Lupus Organ Damage

Researchers from University of Manchester, UK shared findings at ACR on risk factors and one protective medication that may improve the health of people living with lupus.

In a press release issued by the ACR, lead investigator Ian N Bruce, MD, FRCP; professor of rheumatology at the University of Manchester, UK; current chair of the SLICC Inception Cohort said, "Early tissue and organ damage in people with lupus can predict the likelihood of future damage and death due to the disease.” Dr. Bruce's team found that increased disease activity, high blood pressure, and use of steroid treatments were associated with worsening damage, while the use of antimalarial drugs seemed to protect against worsening damage.